Former Sangamo CSO Gregory Heads to Bluebird Bio
Bluebird Bio (NASDAQ: BLUE) hired former Sangamo Biosciences (NASDAQ: SGMO) chief scientific officer and research chief Phillip Gregory as its new CSO.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xpertise: Watch + Learn
From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes
From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities